Skip to main content
AstraZeneca Pharma India Limited (NSE:ASTRAZEN)
India flag India · Delayed Price · Currency is INR
9,226.50
+23.50 (0.26%)
At close: Dec 5, 2025

AstraZeneca Pharma India Revenue

AstraZeneca Pharma India had revenue of 5.59B INR in the quarter ending September 30, 2025, with 37.03% growth. This brings the company's revenue in the last twelve months to 20.06B, up 35.14% year-over-year. In the fiscal year ending March 31, 2025, AstraZeneca Pharma India had annual revenue of 17.16B with 32.48% growth.

Revenue (ttm)
20.06B
Revenue Growth
+35.14%
P/S Ratio
11.48
Revenue / Employee
33.44M
Employees
802
Market Cap
230.29B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 202517.16B4.21B32.48%
Mar 31, 202412.96B2.93B29.17%
Mar 31, 202310.03B1.97B24.50%
Mar 31, 20228.06B-79.60M-0.98%
Mar 31, 20218.14B-182.50M-2.19%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sun Pharmaceutical Industries 549.64B
Divi's Laboratories 100.29B
Cipla 279.66B
Apollo Hospitals Enterprise 232.65B
Zydus Lifesciences 244.94B
Mankind Pharma 135.46B
Aurobindo Pharma 325.14B
Fortis Healthcare 84.37B
Revenue Rankings

AstraZeneca Pharma India News

More News